BioSpace News Archive

The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).

Life Spine announced today that the state of the art PROLIFT® Expandable Spacer System has grown 70% in revenues from the first half of 2018 over the same period the prior year.

Social Model Recovery Systems (SMRS) and the California Consortium of Addiction Programs and Professionals (CCAPP) have partnered to present the inaugural Western States Opioid Summit (WSOS) on September 19-21, 2018, at the Anaheim Convention Center.

Continuum Clinical’s Nariman Nasser, vice president of site engagement has been recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry.”

Today, Nuevolution AB (publ) announced the identity of its “Cytokine X” program being a lead discovery program targeting inhibition of Interleukin IL-17A using small molecules.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will host the live video broadcast “Novel Immunotherapy Options for the Long-term Care of Patients with Chronic Lymphocytic Leukemia (CLL): The Role of Clinical and Specialty Pharmacists.”

Masquerage returns on October 26, 2018! Equitas Health’s Dayton region signature event raises critical funds for the community-based healthcare system’s life-saving work.

In a Viewpoint paper published in Circulation Research, the Phase III CardiAMP Heart Failure Trial studying the investigational CardiAMP stem cell therapy from BioCardia®, Inc. was highlighted as an example of personalized medicine, with promising results from the first 10 patients in the roll-in cohort reported.

U.S. Healthcare System’s largest network of podcasts about the profession and business of pharmacy targeting consumer audience.

GNS Healthcare (GNS), a leading precision medicine company, announced the hiring of veteran software executive Scott McKay as Chief Technology Officer.